December 11, 2025 · Form 4 insider transaction
Giordano Natasha bought 38,320 shares of ORAGENICS INC at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Represents an initial equity award upon appointment to the Company's board of directors (the "Board") of options pursuant to the non-employee director compensation program to purchase shares of the Company's common stock under the Company's 2021 Equity Incentive Plan that vests immediately. The option exercise price is the Company's closing price on the date immediately prior to the reporting person's appointment to the Company's Board. The Board granted the options on December 11, 2025.